Get the Stockscreener App
97.21
0.55%
-0.36
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $97.21, with a volume of 407.92K.
It is down -0.55% in the last 24 hours and down -15.41% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$97.57
Open:
$97.56
24h Volume:
407.92K
Relative Volume:
0.27
Market Cap:
$11.01B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
41.37
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
-2.88%
1M Performance:
-15.41%
6M Performance:
+6.36%
1Y Performance:
-15.71%
1-Day Range:
$95.24
$97.56
1-Week Range:
$95.24
$101.37
52-Week Range:
$81.36
$120.39
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
97.13 | 11.06B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
516.30 | 192.99B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
208.62 | 148.11B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
657.64 | 52.49B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
118.25 | 35.28B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
317.26 | 31.33B | 3.17B | 642.63M | 516.49M | 10.77 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity’s AI Push Brings Innovation Potential but Heightened Operational, Legal, and Reputational Risks - TipRanks
Insider Sell: Michelle Mcmurry-heath Sells Shares of Revvity Inc (RVTY) - GuruFocus
Decoding Revvity Inc (RVTY): A Strategic SWOT Insight - GuruFocus
How Investors May Respond To Revvity (RVTY) Strong Q4 Beat And Upbeat 2026 Outlook - Yahoo Finance
Revvity : Annual Report for Fiscal Year Ending 12/28, 2025 (Form 10-K) - marketscreener.com
Bond Watch: Is Revvity Inc showing insider buyingJuly 2025 PostEarnings & Expert-Curated Trade Recommendations - baoquankhu1.vn
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - The Globe and Mail
Do Wall Street Analysts Like Revvity Stock? - inkl
Can Revvity Inc. stock hit record highs againExit Point & Risk Controlled Daily Plans - mfd.ru
King Luther Capital Management Corp Has $10.45 Million Stake in Revvity Inc. $RVTY - MarketBeat
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - MSN
Revvity tackles hidden TB threat with early testing strategy - Traders Union
Bretton Fund exits UNP and RVTY - MSN
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of “Hold” by Analysts - Defense World
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today - MSN
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - MSN
How To YieldBoost Revvity To 22.5% Using Options - Nasdaq
First National Bank of Omaha Buys New Position in Revvity Inc. $RVTY - MarketBeat
Revvity to Present at Upcoming Investor Conferences - pharmiweb.com
A major biomanufacturer is cutting over 100 jobs in Mass. - MSN
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Pioneer With 24.51% Upside Potential - DirectorsTalk Interviews
Discipline and Rules-Based Execution in RVTY Response - Stock Traders Daily
What’s the beta of Revvity Inc. stockJuly 2025 Setups & Technical Pattern Alert System - mfd.ru
Can Revvity Inc. stock double in the next yearMarket Trend Summary & Verified Technical Signals - mfd.ru
Revvity Expands Drug Discovery Tools As Investors Weigh Growth And Valuation - Sahm
Here's Why Revvity (RVTY) is a Strong Momentum Stock - Eastern Progress
With Revvity, Inc. (NYSE:RVTY) It Looks Like You'll Get What You Pay For - 富途牛牛
Will Revvity Inc. stock see insider buyingSwing Trade & Capital Efficiency Focused Ideas - mfd.ru
New York Life Investment Management LLC Acquires 11,583 Shares of Revvity Inc. $RVTY - MarketBeat
A | Is Revvity, Inc. showing insider buyingJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - mfd.ru
What insider trading reveals about Revvity Inc. stockQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - mfd.ru
Revvity Unveils SLAS2026 Platforms As Valuation Gap Attracts Attention - Sahm
Can Revvity Inc. outperform in the next rallyJuly 2025 Gainers & Reliable Entry Point Trade Alerts - mfd.ru
Revvity boosts momentum at SLAS2026 with full session lineup - Traders Union
Optical Preclinical Imaging Market size to hit $982.8 Million - openPR.com
Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside - Sahm
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization - GlobeNewswire Inc.
Revvity showcases industry insights at SLAS2026 opening - Traders Union
Revvity, Inc. (RVTY) Stock Analysis: A Potential 17.69% Upside in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
Winners Losers: Can Revvity Inc outperform in the next rally2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Diamond Hill Capital Management Inc. Acquires New Holdings in Revvity Inc. $RVTY - MarketBeat
Downgrade Watch: Is Revvity Inc showing insider buyingInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn
Revvity stock rating reiterated at Overweight by KeyBanc - Investing.com Nigeria
Revvity delivers Q4 beat as earnings and revenue top forecasts - MSN
Assessing Revvity (RVTY) Valuation After New SLAS2026 Lab Automation Launches - Sahm
Momentum Shift: Is Revvity Inc impacted by rising ratesQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Revvity Inc (RVTY) Shares Gap Down to $100.55 on Feb 5 - GuruFocus
Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine? - simplywall.st
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - ChartMill
Truist Financial Corp Decreases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):